Pseudomycoicidin, a class II Lantibiotic from Bacillus pseudomycoides

Applied and Environmental Microbiology

Volumn 81, Issue 10, 2015, Pages 3419-3429

  Basi Chipalu, Shradha ^a   Dischinger, Jasmin ^a   Josten, Michaele ^a   Szekat, Christiane ^a   Zweynert, Annegret ^a   Sahl, Hans Georg ^a   Bierbaum, Gabriele ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BACTERIA; BACTERIOLOGY; BIOSYNTHESIS; COVALENT BONDS; DEHYDRATION; ENZYMES; ESCHERICHIA COLI; GENE EXPRESSION; GENES; PEPTIDES;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; ANTIMICROBIAL SUBSTANCE; BIOSYNTHETIC ENZYMES; GRAM-POSITIVE BACTERIUM; HETEROLOGOUS EXPRESSION; MASS SPECTROMETRIC ANALYSIS; POST-TRANSLATIONAL MODIFICATIONS;

MICROORGANISMS;

AMINO ACID; ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; ENZYME; GENE EXPRESSION; PEPTIDE;

BACILLUS PSEUDOMYCOIDES; ESCHERICHIA COLI; POSIBACTERIA;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIOCIN;

AMINO ACID SEQUENCE; BACILLUS; CHEMISTRY; DRUG EFFECTS; GENETICS; GRAM POSITIVE BACTERIUM; METABOLISM; MOLECULAR GENETICS; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACILLUS; BACTERIAL PROTEINS; BACTERIOCINS; GRAM-POSITIVE BACTERIA; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 84930025291     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00299-15     Document Type: Article

References (65)

1. Schnell N, Entian KD, Schneider U, Götz F, Zähner H, Kellner R, Jung G. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings Nature 333:276-278. http://dx.doi .org/10.1038/333276a0.
2. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian KD, Fischbach MA, Garavelli JS, Goransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJ, Rebuffat S, Ross RP, Sahl HG, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Süssmuth RD, Tagg JR, Tang GL, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA. 2013. Ribosomally synthesized and posttranslationally modified peptide natural products: overview and recommendations for a universal nomenclature Nat Prod Rep 30:108-160. http://dx.doi.org/10.1039/C2NP20085F.
3. Ingram LC. 1969. Synthesis of the antibiotic nisin: formation of lanthionine and beta-methyl-lanthionine Biochim Biophys Acta 184:216-219. http://dx.doi.org/10.1016/0304-4165(69)90121-4.
4. Ingram L. 1970. A ribosomal mechanism for synthesis of peptides related to nisin Biochim Biophys Acta 224:263-265. http://dx.doi.org/10.1016/0005-2787(70)90642-8.
5. Garg N, Salazar-Ocampo LM, van der Donk WA. 2013. In vitro activity of the nisin dehydratase NisB Proc Natl Acad Sci U S A 110:7258-7263. http://dx.doi.org/10.1073/pnas.1222488110.
6. Meyer C, Bierbaum G, Heidrich C, Reis M, Süling J, Iglesias-Wind MI, Kempter C, Molitor E, Sahl HG. 1995. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC Evidence for a role of PepC in thioether formation. Eur J Biochem 232:478-489.
7. Xie L, Miller LM, Chatterjee C, Averin O, Kelleher NL, van der Donk WA. 2004. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity Science 303:679-681. http://dx.doi.org/10.1126/science.1092600.
8. Draper LA, Ross RP, Hill C, Cotter PD. 2008. Lantibiotic immunity Curr Protein Pept Sci 9:39-49. http://dx.doi.org/10.2174/138920308 783565750.
9. Willey JM, van der Donk WA. 2007. Lantibiotics: peptides of diverse structure and function Annu Rev Microbiol 61:477-501. http://dx.doi .org/10.1146/annurev.micro.61.080706.093501.
10. Cotter PD, Hill C, Ross RP. 2005. Bacteriocins: developing innate immunity for food Nat Rev Microbiol 3:777-788. http://dx.doi.org/10.1038/nrmicro1273.
11. Lubelski J, Rink R, Khusainov R, Moll GN, Kuipers OP. 2008. Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin Cell Mol Life Sci 65:455-476. http://dx.doi.org/10.1007/s00018-007-7171-2.
12. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl H, de Kruijff B. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic Science 286:2361-2364. http://dx.doi.org/10.1126/science.286.5448.2361.
13. Kodani S, Hudson ME, Durrant MC, Buttner MJ, Nodwell JR, Willey JM. 2004. The SapB morphogen is a lantibiotic-like peptide derived from the product of the developmental gene ramS in Streptomyces coelicolor Proc Natl Acad Sci U S A 101:11448-11453. http://dx.doi.org/10.1073/pnas.0404220101.
14. Müller WM, Schmiederer T, Ensle P, Süssmuth RD. 2010. In vitro biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin A2 including formation of a C-C bond as a posttranslational modification Angew Chem Int Ed Engl 49:2436-2440. http://dx.doi.org/10.1002/anie .200905909.
15. McClerren AL, Cooper LE, Quan C, Thomas PM, Kelleher NL, van der Donk WA. 2006. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic Proc Natl Acad Sci U S A 103:17243-17248. http://dx.doi.org/10.1073/pnas.0606088103.
16. Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G. 2009. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13 PLoS One 4:e6788. http://dx.doi.org/10.1371/journal .pone.0006788.
17. Begley M, Cotter PD, Hill C, Ross RP. 2009. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins Appl Environ Microbiol 75:5451-5460. http://dx.doi .org/10.1128/AEM.00730-09.
18. Daly KM, Upton M, Sandiford SK, Draper LA, Wescombe PA, Jack RW, O'Connor PM, Rossney A, Götz F, Hill C, Cotter PD, Ross RP, Tagg JR. 2010. Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains J Bacteriol 192:1131-1142. http://dx.doi.org /10.1128/JB.01375-09.
19. Goto Y, Li B, Claesen J, Shi Y, Bibb MJ, van der Donk WA. 2010. Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights PLoS Biol 8:e1000339. http://dx.doi.org/10.1371/journal.pbio.1000339.
20. Li B, Sher D, Kelly L, Shi Y, Huang K, Knerr PJ, Joewono I, Rusch D, Chisholm SW, van der Donk WA. 2010. Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria Proc Natl Acad Sci U S A 107:10430-10435. http://dx.doi .org/10.1073/pnas.0913677107.
21. van Heel AJ, Mu D, Montalban-Lopez M, Hendriks D, Kuipers OP. 2013. Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes ACS Synth Biol 2:397-404. http://dx.doi.org/10.1021/sb3001084.
22. Ryan MP, McAuliffe O, Ross RP, Hill C. 2001. Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin Lett Appl Microbiol 32:71-77. http://dx.doi.org/10.1046/j .1472-765x.2001.00864.x.
23. Caetano T, Krawczyk JM, Mosker E, Süssmuth RD, Mendo S. 2011. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli Chem Biol 18:90-100. http://dx.doi.org/10.1016/j.chembiol.2010.11.010.
24. Shi Y, Bueno A, van der Donk WA. 2012. Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli Chem Commun (Cambridge) 48:10966-10968. http://dx.doi.org/10.1039/c2cc36336d.
25. Nagao J, Shioya K, Harada Y, Okuda K, Zendo T, Nakayama J, Sonomoto K. 2011. Engineering unusual amino acids into peptides using lantibiotic synthetase Methods Mol Biol 705:225-236. http://dx.doi.org /10.1007/978-1-61737-967-3_13.
26. Okesli A, Cooper LE, Fogle EJ, van der Donk WA. 2011. Nine posttranslational modifications during the biosynthesis of cinnamycin J Am Chem Soc 133:13753-13760. http://dx.doi.org/10.1021/ja205783f.
27. Altena K, Guder A, Cramer C, Bierbaum G. 2000. Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster Appl Environ Microbiol 66:2565-2571. http://dx.doi.org/10.1128/AEM .66.6.2565-2571.2000.
28. Zwick ME, Joseph SJ, Didelot X, Chen PE, Bishop-Lilly KA, Stewart AC, Willner K, Nolan N, Lentz S, Thomason MK, Sozhamannan S, Mateczun AJ, Du L, Read TD. 2012. Genomic characterization of the Bacillus cereus sensu lato species: backdrop to the evolution of Bacillus anthracis Genome Res 22:1512-1524. http://dx.doi.org/10.1101/gr .134437.111.
29. Chopra L, Singh G, Choudhary V, Sahoo DK. 2014. Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93 Appl Environ Microbiol 80:2981-2990. http://dx.doi.org/10.1128/AEM .04259-13.
30. Haft DH. 2009. A strain-variable bacteriocin in Bacillus anthracis and Bacillus cereus with repeated Cys-Xaa-Xaa motifs Biol Direct 4:15. http://dx.doi.org/10.1186/1745-6150-4-15.
31. Nakamura LK. 1998. Bacillus pseudomycoides sp nov. Int J Syst Bacteriol 48:1031-1035. http://dx.doi.org/10.1099/00207713-48-3-1031.
32. Bertani G. 1951. Studies on lysogenesis I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62:293-300.
33. Sass P, Bierbaum G. 2009. Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides Int J Med Microbiol 299:313-322. http://dx.doi.org/10.1016/j.ijmm.2008.10.005.
34. Schleifer KH, Fischer U. 2002. Description of a new species of the genus Staphylococcus: Staphylococcus carnosus Int J Syst Bacteriol 32:153-156. http://dx.doi.org/10.1099/00207713-32-2-153.
35. Bierbaum G, Sahl HG. 1987. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-Lalanine amidase J Bacteriol 169:5452-5458.
36. Sass P, Bierbaum G. 2007. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus Appl Environ Microbiol 73:347-352. http://dx.doi.org/10.1128/AEM.01616-06.
37. Wang H, van der Donk WA. 2012. Biosynthesis of the class III lantipeptide catenulipeptin ACS Chem Biol 7:1529-1535. http://dx.doi.org/10.1021/cb3002446.
38. Bierbaum G, Brötz H, Koller KP, Sahl HG. 1995. Cloning, sequencing and production of the lantibiotic mersacidin FEMS Microbiol Lett 127:121-126. http://dx.doi.org/10.1111/j.1574-6968.1995.tb07460.x.
39. Paul M, Patton GC, van der Donk WA. 2007. Mutants of the zinc ligands of lacticin 481 synthetase retain dehydration activity but have impaired cyclization activity Biochemistry 46:6268-6276. http://dx.doi.org/10.1021/bi7000104.
40. Kataeva IA, Yang SJ, Dam P, Poole FL, Yin Y, Zhou F, Chou WC, Xu Y, Goodwin L, Sims DR, Detter JC, Hauser LJ, Westpheling J, Adams MW. 2009. Genome sequence of the anaerobic, thermophilic, and cellulolytic bacterium "Anaerocellum thermophilum" DSM 6725 J Bacteriol 191:3760-3761. http://dx.doi.org/10.1128/JB.00256-09.
41. Dischinger J, Basi Chipalu S, Bierbaum G. 2014. Lantibiotics: promising candidates for future applications in health care Int J Med Microbiol 304:51-62. http://dx.doi.org/10.1016/j.ijmm.2013.09.003.
42. Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F. 2008. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens Chem Biol 15:22-31. http://dx .doi.org/10.1016/j.chembiol.2007.11.009.
43. Rea MC, Clayton E, O'Connor PM, Shanahan F, Kiely B, Ross RP, Hill C. 2007. Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains J Med Microbiol 56:940-946. http://dx.doi.org/10.1099/jmm.0.47085-0.
44. Chen XH, Koumoutsi A, Scholz R, Schneider K, Vater J, Süssmuth R, Piel J, Borriss R. 2009. Genome analysis of Bacillus amyloliquefaciens FZB42 reveals its potential for biocontrol of plant pathogens J Biotechnol 140:27-37. http://dx.doi.org/10.1016/j.jbiotec.2008.10.011.
45. Scholz R, Molohon KJ, Nachtigall J, Vater J, Markley AL, Süssmuth RD, Mitchell DA, Borriss R. 2011. Plantazolicin, a novel microcin B17/ streptolysin S-like natural product from Bacillus amyloliquefaciens FZB42 J Bacteriol 193:215-224. http://dx.doi.org/10.1128/JB.00784-10.
46. Stein T. 2005. Bacillus subtilis antibiotics: structures, syntheses and specific functions Mol Microbiol 56:845-857. http://dx.doi.org/10.1111/j .1365-2958.2005.04587.x.
47. Oman TJ, van der Donk WA. 2010. Follow the leader: the use of leader peptides to guide natural product biosynthesis Nat Chem Biol 6:9-18. http://dx.doi.org/10.1038/nchembio.286.
48. Islam MR, Nishie M, Nagao J, Zendo T, Keller S, Nakayama J, Kohda D, Sahl HG, Sonomoto K. 2012. Ring A of nukacin ISK-1: a lipid IIbinding motif for type-A(II) lantibiotic J Am Chem Soc 134:3687-3690. http://dx.doi.org/10.1021/ja300007h.
49. Schibli DJ, Epand RF, Vogel HJ, Epand RM. 2002. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions Biochem Cell Biol 80:667-677. http://dx.doi.org/10.1139/o02-147.
50. Chan DI, Prenner EJ, Vogel HJ. 2006. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action Biochim Biophys Acta 1758:1184-1202. http://dx.doi.org/10.1016/j.bbamem.2006.04.006.
51. Fimland G, Eijsink VG, Nissen-Meyer J. 2002. Mutational analysis of the role of tryptophan residues in an antimicrobial peptide Biochemistry 41:9508-9515. http://dx.doi.org/10.1021/bi025856q.
52. Bierbaum G, Szekat C, Josten M, Heidrich C, Kempter C, Jung G, Sahl HG. 1996. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5 Appl Environ Microbiol 62:385-392.
53. Jarvis B, Mahoney RR. 1969. Inactivation of nisin by alphachymotrypsin J Dairy Sci 52:1448-1449. http://dx.doi.org/10.3168/jds .S0022-0302(69)86771-8.
54. Allgaier H, Jung G, Werner RG, Schneider U, Zähner H. 1986. Epidermin:sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic Eur J Biochem 160:9-22. http://dx.doi.org/10.1111/j.1432-1033.1986.tb09933.x.
55. Cooper LE, McClerren AL, Chary A, van der Donk WA. 2008. Structure- activity relationship studies of the two-component lantibiotic haloduracin Chem Biol 15:1035-1045. http://dx.doi.org/10.1016/j.chembiol .2008.07.020.
56. Holo H, Jeknic Z, Daeschel M, Stevanovic S, Nes IF. 2001. Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics Microbiology 147:643-651.
57. Sawa N, Wilaipun P, Kinoshita S, Zendo T, Leelawatcharamas V, Nakayama J, Sonomoto K. 2012. Isolation and characterization of enterocin W, a novel two-peptide lantibiotic produced by Enterococcus faecalis NKR-4-1 Appl Environ Microbiol 78:900-903. http://dx.doi.org/10.1128/AEM.06497-11.
58. Zhang J, Feng Y, Teng K, Lin Y, Gao Y, Wang J, Zhong J. 2014. Type AII lantibiotic bovicin HJ50 with a rare disulfide bond: structure, structureactivity relationships and mode of action Biochem J 461:497-508. http://dx.doi.org/10.1042/BJ20131524.
59. Wang J, Ma H, Ge X, Zhang J, Teng K, Sun Z, Zhong J. 2014. Bovicin HJ50-like lantibiotics, a novel subgroup of lantibiotics featured by an indispensable disulfide bridge PLoS One 9:e97121. http://dx.doi.org/10.1371/journal.pone.0097121.
60. Majchrzykiewicz JA, Lubelski J, Moll GN, Kuipers A, Bijlsma JJ, Kuipers OP, Rink R. 2010. Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence Antimicrob Agents Chemother 54:1498-1505. http://dx.doi.org/10.1128/AAC.00883-09.
61. Patton GC, Paul M, Cooper LE, Chatterjee C, van der Donk WA. 2008. The importance of the leader sequence for directing lanthionine formation in lacticin 481 Biochemistry 47:7342-7351. http://dx.doi.org/10.1021/bi800277d.
62. Mukherjee S, van der Donk WA. 2014. Mechanistic studies on the substrate-tolerant lanthipeptide synthetase ProcM J Am Chem Soc 136:10450-10459. http://dx.doi.org/10.1021/ja504692v.
63. Herzner AM, Dischinger J, Szekat C, Josten M, Schmitz S, Yakeleba A, Reinartz R, Jansen A, Sahl HG, Piel J, Bierbaum G. 2011. Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42 PLoS One 6:e22389. http://dx.doi.org/10.1371/journal.pone.0022389.
64. Takami H, Nakasone K, Takaki Y, Maeno G, Sasaki R, Masui N, Fuji F, Hirama C, Nakamura Y, Ogasawara N, Kuhara S, Horikoshi K. 2000. Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis Nucleic Acids Res 28:4317-4331. http://dx.doi.org/10.1093/nar/28.21.4317.
65. Veith B, Herzberg C, Steckel S, Feesche J, Maurer KH, Ehrenreich P, Baumer S, Henne A, Liesegang H, Merkl R, Ehrenreich A, Gottschalk G. 2004. The complete genome sequence of Bacillus licheniformis DSM13, an organism with great industrial potential J Mol Microbiol Biotechnol 7:204-211. http://dx.doi.org/10.1159/000079829.